SCHWIND eye-tech-solutions develops, produces and markets a comprehensive product portfolio for the SCHWIND is not a jack of all trades. Nor do we want to be.
SCHWIND eye-tech-solutions is one of the technology leaders for eye lasers for refractive and therapeutic corneal surgery. We develop, produce and market a comprehensive product portfolio for the treatment of vision defects and corneal diseases. This includes the sophisticated SCHWIND AMARIS excimer laser product family, SCHWIND ATOS femtosecond laser, diagnostic systems, and treatment planning tools for a uniquely wide scope of applications. After all, real performance only comes when you focus on one goal. Our goal is to give the eye surgeon the best possible tools to work with, so that patients can enjoy better vision and quality of life. A long list of benefits in the precision, safety, speed, and ease of use of our solutions proves the viability of this approach. We cultivate a culture of innovation. In research and development, our highly motivated, experienced team of software and hardware developers and biomedical engineers ensures the future success of SCHWIND technologies. We work closely with our users to ensure the practicality of our developments. This has enabled to us to repeatedly redefine the state of the art with completely new solutions.
20/02/2026
Meet the Expert at the 30th ESCRS Winter Meeting in Helsinki, Finland!
Join us at SCHWIND Booth S07 for an exclusive exchange of experiences with Dr. Jarno Ylitalo.
Take the opportunity to discuss innovations in refractive surgery and gain practical insights from a leading expert.
We look forward to welcoming you!
19/02/2026
Lenticule extraction with SCHWIND ATOS is rapidly gaining momentum worldwide, earning strong appreciation from both surgeons and patients. Numerous clinical publications confirm that the learning curve is manageable and the outcomes continue to impress surgeons. With the introduction of CenTrax technology, the capability of SCHWIND ATOS is further enhanced enabling it to perform SmartSight NOVA the advanced lenticule extraction procedure.
Congratulations to Dr. Kishore Pradhan for successfully performing more than 1000 SmartSight NOVA procedures with SCHWIND ATOS!
19/02/2026
From systems to solutions.
SCHWIND’s Chief Sales and Marketing Officer, Lars Michael, shares how the company is moving beyond system sales to deliver integrated solutions.
From clinical expertise and training to personalized post-sales support, this expanded model is designed to help partners and surgeons deliver better outcomes and business performance while strengthening SCHWIND’s role as a long-term partner in refractive excellence.
For more information, please visit our website - link in bio.
17/02/2026
Happy Chinese New Year! 🧧
As we welcome the new lunar year, we wish you health, happiness, and continued success – both personally and professionally. May the year ahead bring new opportunities and turn shared visions into reality.
10/02/2026
PresbyMAX takes center stage at this year’s ESCRS Winter Meeting.
The 30th ESCRS Winter Meeting will take place in Helsinki, Finland, bringing together the ophthalmology community for three days of innovation and exchange.
📍 Messukeskus Helsinki Expo and Convention Centre
📅 06–08 March 2026
🎯 SCHWIND Booth S07
With presbyopia treatment in focus, visit SCHWIND booth and discover how SCHWIND PresbyMAX continues to support surgeons with a proven, clinically established solution.
Last week, SMS Healthcare hosted an outstanding Wet Lab to celebrate the official opening of Victoria’s second Laser Eye Surgery Centre (LESC) location in Richmond.
The evening showcased the strength of the SMS surgical network, bringing together specialists, VMOs, and clinical teams for hands-on learning, peer exchange, and meaningful discussion.
Enjoy the highlights from the evening.
22/01/2026
Refractive surgery has only just begun.
SCHWIND CEO Domenic von Planta believes refractive surgery should be the first choice for vision correction—freeing patients from glasses, contacts, and their complications. With just 5% of the potential population treated so far, there’s still so much more to achieve. Every day, 4,000 eyes are treated on SCHWIND technology. Our mission: reach 10,000+ and help more people enjoy life with better vision.
19/01/2026
Save the Date! ✨
The 30th ESCRS Winter Meeting is heading to Helsinki, Finland
📅 06–08 March 2026
📍 Messukeskus Helsinki Expo and Convention Centre
🔎 Visit us at Booth S07
Get ready for cutting-edge innovation and valuable insights in ophthalmology. See you there!
08/01/2026
Prof. Dr. Li Ying shares how SCHWIND PresbyMAX enables precise, patient-tailored presbyopia treatment—helping patients with high near-vision demands maintain both functional near vision and excellent distance acuity. A powerful solution for modern presbyopic patients.
To know more about PresbyMAX, visit our website: link in the bio!
19/12/2025
Season’s Greetings from SCHWIND! ❄️🎅
From all of us at SCHWIND, we wish you a holiday season full of laughter, joy, and maybe even a little bit of magic! ✨🎄
Thank you for being part of our journey — we look forward to a bright New Year together!
18/12/2025
Discover how leading eye surgeons — Dr. Jerry Tan, Dr. Luis Izquierdo, Dr. Riccardo Vinciguerra, and Dr. Victor Derhartunian — explain how leveraging CenTraX technology in the SCHWIND ATOS helps them elevate surgical precision and outcomes.
With automated centration, SCHWIND’s advanced femtosecond laser technology delivers outstanding results for patients.
Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Schwind eye-tech-solutions GmbH erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.
Die Praxis Kontaktieren
Nachricht an Schwind eye-tech-solutions GmbH senden:
SCHWIND eye-tech-solutions is a specialist for refractive and therapeutic corneal surgery. The company develops, produces and markets a comprehensive product portfolio for the treatment of ametropia and corneal diseases. For more than 60 years of steady growth and development, the owner operated family enterprise has advanced from diagnostics technology supplier for ophthalmologic practices to one of the technology leaders in eye laser systems.
SCHWIND is present in more than 100 countries worldwide. Sales and distribution takes place in Germany through the company’s own organisation, and in all other markets through carefully selected distribution partners. 140 highly qualified employees dedicate all their know-how and all their creativity to the aim of optimizing vision. About 1,900 SCHWIND laser systems have been already installed. Customers include refractive surgeons in eye practices, eye clinics, laser centers and university clinics.
SCHWIND eye-tech-solutions is one of the technology leaders for eye lasers for refractive and therapeutic corneal surgery. Due to the high development speed, the company is often ahead of its competitors in terms of the new and further development of products and services. SCHWIND continuously sets new standards in high technology. The major technological achievements are developed in-house - guided by market requirements and in close co-operation with the users of SCHWIND technology. Beyond that, the company differs from its competitors by combining the marketing of high-technology products with the positive characteristics of a family business.
We facilitate the best and safest working results for our partners, the refractive and therapeutic corneal surgeons - and a better quality of life for the patients:
Because we continuously develop sophisticated technological product solutions.
Because we offer a comprehensive product and support spectrum worldwide.
Because solutions for our partners take centre stage in everything we do. Flexible, fast and with an economic sense of proportion.
Because we are always available for our customers - competent, friendly and helpful.
In the assertion of user rights, we point out to make this claim directly on Facebook. Only Facebook has access to the users' data and can directly take appropriate action and provide information.